The heaviest legal penalties imposed on drug companies concern interactions with healthcare professionals in the context of prescription drug marketing, notably for violations of the Anti-Kickback Statute and the False Claims Act. Monetary penalties have amounted to billions of dollars in some cases.
This e-learning course will help you and your staff become familiar with the role and responsibilities of the designated safeguarding lead in your organisation. It will develop both your competence and confidence in carrying out the role of Designated Safeguarding Lead (DSL).